Literature DB >> 24372100

Specific causes of death in patients with bullous pemphigoid as measured by death certificate data: a retrospective cohort study.

Benjamin J Barrick1, Christine M Lohse, Julia S Lehman.   

Abstract

BACKGROUND: Mortality rates in patients with bullous pemphigoid (BP) are higher than those in age-matched counterparts. However, the specific causes of death in BP subjects have not been evaluated systematically.
OBJECTIVES: We sought to characterize the causes of death in patients with BP as recorded by death certificate and to compare these with death data for age- and location-matched control subjects.
METHODS: This was a retrospective cohort analysis conducted in a large tertiary referral center. Twenty-seven participants who had a confirmed antemortem diagnosis of BP, were residents of Olmsted County, Minnesota, and had died between January 1, 1999, and January 1, 2009, were included in the study. Underlying cause of death and multiple causes of death data for the study population were compared with data sourced from the Centers for Disease Control and Prevention (CDC) for a control group matched by age and geographic location of origin by International Classification of Diseases, 10th Revision (ICD-10) block, and specific ICD-10 codes.
RESULTS: Comparisons of specific ICD-10 codes revealed increased rates of sepsis (P = 0.031), dementia (P = 0.049), and major depressive disorder (P = 0.005) in the study group. The collective incidence of ICD-10 codes for infections indicated that infections were more frequent contributors to death in the study group (P = 0.035).
CONCLUSIONS: Clinicians should be mindful of contributors to death in patients with BP and might consider screening for mental health issues, educating patients on the early symptoms of sepsis, and minimizing risk factors for infection.
© 2013 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2013        PMID: 24372100      PMCID: PMC4076375          DOI: 10.1111/ijd.12243

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  22 in total

1.  Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Cynthia L Leibson; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

Review 2.  Quality-of-life measurement in blistering diseases.

Authors:  Deshan F Sebaratnam; John W Frew; Fereydoun Davatchi; Dédée F Murrell
Journal:  Dermatol Clin       Date:  2011-12-20       Impact factor: 3.478

3.  Louisiana death certificate accuracy: a concern for the public's health.

Authors:  Clarissa J B Hoff; Raoult Ratard
Journal:  J La State Med Soc       Date:  2010 Nov-Dec

4.  Mortality of bullous pemphigoid in Switzerland: a prospective study.

Authors:  B Cortés; G Marazza; L Naldi; C Combescure; L Borradori
Journal:  Br J Dermatol       Date:  2011-08       Impact factor: 9.302

5.  Infection and infection prevention in patients treated with immunosuppressive medications for autoimmune bullous disorders.

Authors:  Julia S Lehman; Dédée F Murrell; Michael J Camilleri; Amer N Kalaaji
Journal:  Dermatol Clin       Date:  2011-10       Impact factor: 3.478

6.  Increased risk of stroke in patients with bullous pemphigoid: a population-based follow-up study.

Authors:  Ya-Wen Yang; Yi-Hua Chen; Sudha Xirasagar; Herng-Ching Lin
Journal:  Stroke       Date:  2010-12-16       Impact factor: 7.914

7.  The relationship between neurological disease and bullous pemphigoid: a population-based case-control study.

Authors:  Sinéad M Langan; Richard W Groves; Joe West
Journal:  J Invest Dermatol       Date:  2010-11-18       Impact factor: 8.551

8.  Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.

Authors:  Sylvie Bastuji-Garin; Pascal Joly; Pauline Lemordant; Agnès Sparsa; Christophe Bedane; Emmanuel Delaporte; Jean-Claude Roujeau; Philippe Bernard; Jean-Claude Guillaume; Saskia Ingen-Housz-Oro; Hervé Maillard; Catherine Pauwels; Catherine Picard-Dahan; Yes Dutronc; Marie-Aleth Richard
Journal:  J Invest Dermatol       Date:  2010-10-14       Impact factor: 8.551

9.  Mortality rate of bullous pemphigoid in a US medical center.

Authors:  Rand L Colbert; David M Allen; Daniel Eastwood; Janet A Fairley
Journal:  J Invest Dermatol       Date:  2004-05       Impact factor: 8.551

10.  Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group.

Authors:  L Vaillant; P Bernard; P Joly; C Prost; B Labeille; C Bedane; B Arbeille; E Thomine; P Bertrand; C Lok; J C Roujeau
Journal:  Arch Dermatol       Date:  1998-09
View more
  4 in total

Review 1.  Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Authors:  Kyle T Amber; Dedee F Murrell; Enno Schmidt; Pascal Joly; Luca Borradori
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

2.  Herpes zoster in patients with bullous pemphigoid: a population-based case-control and cohort study.

Authors:  B J Barrick; J D Barrick; C H Weaver; C M Lohse; C N Wieland; A N Kalaaji; J S Lehman
Journal:  Br J Dermatol       Date:  2016-02-04       Impact factor: 9.302

3.  Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009.

Authors:  Katherine E Brick; Chad H Weaver; Christine M Lohse; Mark R Pittelkow; Julia S Lehman; Michael J Camilleri; Mustafa Al-Hashimi; Carilyn N Wieland
Journal:  J Am Acad Dermatol       Date:  2014-04-03       Impact factor: 11.527

Review 4.  BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.

Authors:  Yale Liu; Liang Li; Yumin Xia
Journal:  Front Immunol       Date:  2017-12-08       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.